Home > Balance Sheet > WINDLAS BIOTECH

WINDLAS BIOTECH
Capital Work in Progress

    Back to Balance Sheet
AD     Remove this Ad

WINDLAS BIOTECH Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Capital Work in Progress ₹3.20 Cr₹5.71 Cr₹14 Cr₹7.58 Cr₹0.04 Cr

What is the latest Capital Work in Progress ratio of WINDLAS BIOTECH ?

The latest Capital Work in Progress ratio of WINDLAS BIOTECH is ₹3.20 Cr based on Mar2025 Consolidated results.
Year Capital Work in Progress
Mar2025₹3.20 Cr
Mar2024₹5.71 Cr
Mar2023₹14 Cr
Mar2022₹7.58 Cr
Mar2021₹0.04 Cr

How is Capital Work in Progress of WINDLAS BIOTECH Trending?

Years Capital Work in Progress % Change
Mar2025 ₹3.20 Cr
-43.92
Mar2024 ₹5.71 Cr
-58.64
Mar2023 ₹14 Cr
82.05
Mar2022 ₹7.58 Cr
20,389.19
Mar2021 ₹0.04 Cr -

Compare Capital Work in Progress of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹1,695.3 Cr -8.3% -3.5% -20.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,431.0 Cr -0.4% -0.1% -2% Stock Analytics
DIVIS LABORATORIES ₹163,772.0 Cr 0.9% -3% 0.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹137,884.0 Cr 2% 1.7% 25.2% Stock Analytics
CIPLA ₹107,503.0 Cr -0.9% -7.2% -9.7% Stock Analytics
DR REDDYS LABORATORIES ₹105,798.0 Cr -0.6% 6.8% 2.7% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

-8.3%

-3.5%

-20.4%

SENSEX

-1.1%

-1.2%

5.9%


You may also like the below Video Courses